Atlas Venture Associates IX, LLC - SURFACE ONCOLOGY INC ownership

SURFACE ONCOLOGY INC's ticker is SURF and the CUSIP is 86877M209. A total of 92 filers reported holding SURFACE ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Atlas Venture Associates IX, LLC ownership history of SURFACE ONCOLOGY INC
ValueSharesWeighting
Q2 2023$2,562,544
+24.3%
2,945,4530.0%14.02%
+44.9%
Q1 2023$2,061,817
-14.6%
2,945,4530.0%9.68%
-19.5%
Q4 2022$2,415,271
-21.1%
2,945,4530.0%12.02%
+32.4%
Q3 2022$3,063,000
-36.6%
2,945,4530.0%9.08%
-17.3%
Q2 2022$4,831,000
-44.2%
2,945,4530.0%10.98%
+37.8%
Q1 2022$8,660,000
-38.5%
2,945,4530.0%7.96%
+29.6%
Q4 2021$14,079,000
-36.9%
2,945,4530.0%6.14%
-17.1%
Q3 2021$22,297,000
+1.5%
2,945,4530.0%7.41%
+91.7%
Q2 2021$21,972,000
-4.4%
2,945,4530.0%3.87%
+0.2%
Q1 2021$22,974,000
-15.6%
2,945,4530.0%3.86%
-10.5%
Q4 2020$27,216,000
-15.1%
2,945,453
-36.6%
4.31%
-87.0%
Q3 2020$32,054,000
+5.2%
4,645,4530.0%33.16%
+1.7%
Q2 2020$30,474,000
+250.8%
4,645,4530.0%32.59%
+77.4%
Q1 2020$8,687,000
-0.5%
4,645,4530.0%18.37%
+20.7%
Q4 2019$8,733,000
+32.4%
4,645,4530.0%15.22%
+40.1%
Q3 2019$6,597,000
-49.6%
4,645,4530.0%10.86%
-22.5%
Q2 2019$13,100,000
-40.9%
4,645,4530.0%14.01%
-32.7%
Q1 2019$22,159,000
+12.5%
4,645,4530.0%20.82%
-8.2%
Q4 2018$19,697,000
-61.2%
4,645,4530.0%22.68%
-15.7%
Q3 2018$50,821,000
-32.9%
4,645,4530.0%26.90%
-19.3%
Q2 2018$75,767,0004,645,45333.35%
Other shareholders
SURFACE ONCOLOGY INC shareholders Q1 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 2,945,453$22,297,0007.41%
ACT CAPITAL MANAGEMENT, LLC 170,500$1,291,0000.67%
SummerHaven Investment Management, LLC 128,078$970,0000.57%
Parkman Healthcare Partners LLC 248,267$1,879,0000.48%
SILVERARC CAPITAL MANAGEMENT, LLC 50,000$379,0000.21%
C M BIDWELL & ASSOCIATES LTD 33,030$250,0000.17%
ARK Investment Management 4,618,354$34,961,0000.08%
Knights of Columbus Asset Advisors LLC 114,594$867,0000.08%
Orbimed Advisors 909,666$6,886,0000.08%
HighVista Strategies LLC 13,932$105,0000.07%
View complete list of SURFACE ONCOLOGY INC shareholders